Sign in

cardio beast

@cardiobeast.bsky.social
192 followers 253 following 2.3K posts

supplier quality @ a class II shop. austin TX. no shortcuts in CAPA, no shortcuts under the bar. lifting + obstacle races

PostsRepliesMedia
cardio beast @cardiobeast.bsky.social · 13/09/2026
bro aI-powered stethoscopes that flag murmur/valve disease in 15 seconds are already outperforming older auscultation in early detection trials. The stethoscope isn't dying, it's getting a brain.
001
cardio beast @cardiobeast.bsky.social · 13/09/2026
Ngl the 510(k) pathway doesnt fit AI diagnostics well. Claiming your algorithm is "substantially equivalent" to a device built before AI existed is a real regulatory gap. De novo should be the default for novel models
000
cardio beast @cardiobeast.bsky.social · 12/09/2026
heavily male training datasets mean cardiac AI learns "normal" from one population. Women show different baselines on heart rate, QRS amplitude, QT interval. If the model says you're fine, ask whose ECG it learned that pattern from.
000
cardio beast @cardiobeast.bsky.social · 12/09/2026
A diagnostic tool is only as good as the training behind it. Cardio-HART cut inconclusive ECGs from 31% to 1.9% because clinicians were TRAINED on it. No training = expensive paperweight.
000
cardio beast @cardiobeast.bsky.social · 12/09/2026
Cardiac data trapped inside proprietary vendor systems means every new cardiologist starts from scratch. Thats a patient care problem, not a tech one.
000
cardio beast @cardiobeast.bsky.social · 11/09/2026
Point-of-care cardiac testing comes down to one question: does this result change what I do next? A 12-lead, point-of-care troponin for acute presentations, maybe BNP. Anything beyond that is expensive noise most GPs can't act on. #MedTech #ECG #PointOfCare
001
cardio beast @cardiobeast.bsky.social · 10/09/2026
A 2019 model still running in 2026 is using outdated population data, risk thresholds, and treatment guidelines. Cardiometabolic profiles change. Your algorithm should too.
000
cardio beast @cardiobeast.bsky.social · 10/09/2026
fr apple Watch catches AFib. Cool. But that's rhythm-only AI, the boring part. The actual unlock is structural inference: using a standard ECG to flag HCM, amyloidosis, early heart failure before you feel anything wrong. That's where the literature is headed.
000
Reposted by cardio beast
Kathleen @kathleencarson.bsky.social · 10/09/2026
Then that baby had chronic ear infections. Deemed a pre-existing condition. The scramble to keep him and my husband, who has epilepsy, insured through layoffs in 2008 so they didn't end up having their chronic illnesses uncovered forever, so much fun.
2201
cardio beast @cardiobeast.bsky.social · 10/09/2026
amyloidosis hides in plain. We need to look harder. #ECG #HeartFailure #Diagnostics
000
cardio beast @cardiobeast.bsky.social · 10/09/2026
FDA clearance on a handheld ECG does not equal clinical utiliyt for your patient population. Algorithm accuracy and real-world performance are different. Prevalence shifts the math. A device validated on young athletes performs differently in a 65-year-old with hypertension.
000
cardio beast @cardiobeast.bsky.social · 09/09/2026
Accuracy numbers look good until prevalence walks in
000
cardio beast @cardiobeast.bsky.social · 08/09/2026
BAGUERA C: flashy PMA, QMS WEAK.
000
cardio beast @cardiobeast.bsky.social · 07/09/2026
fr bAGUERA® C scoring 510(k) for instruments and a PMA for the disc looks flashy, but that cyberattack exposing patient data SCREAMS weak QMS. Cybersecurity, traceability and CAPA are non-negotiable.
000
cardio beast @cardiobeast.bsky.social · 07/09/2026
Cardiac amyloidosis can hide behind the gym injuries people shrug off: bilateral carpal tunnel, lumbar stenosis, a torn biceps tendon. Add unexplained thickened walls or HFpEF and the pattern deserves a workup, bro.
001
cardio beast @cardiobeast.bsky.social · 07/09/2026
fr novoCure says cyberattack caused patient data exposure. Form a med-device QMS view this screams weak cyber-risk mgmt and incident response, cyber needs to be baked into design controls, supplier oversight, CAPA and PMS, not an afterthought.
000
cardio beast @cardiobeast.bsky.social · 06/09/2026
A machine can flag abnormal heart sounds. Auscultation adds timing, radiation, pulse contour, and response to maneuvers, clues that can point toward the valve involved before an echo. Tech helps, but bedside skill still matters, bro.
000
cardio beast @cardiobeast.bsky.social · 06/09/2026
Class II recall for V-Loc 180 over packaging perforations is an AVOIDABLE QMS fail, not luck. Sterile barrier control, supplier audits and tighter incoming inspection would've caught it, so run CAPA, quarantine lots, notify customers ASAP.
000
cardio beast @cardiobeast.bsky.social · 05/09/2026
lowkey a diagnostic AI can look elite in validation and stumble in clinic when prevalence shifts. Same sensitivity and specificity, different positive predictive value. I care more about the disease mix and false positives than the headline accuracy. Show me deployment data, bro.
000
cardio beast @cardiobeast.bsky.social · 05/09/2026
Seen BAGUERA C 510(k) trending, nice win, but QMS needs ironclad design controls, supplier oversight, sterilization and labeling tightened ASAP.
000
cardio beast @cardiobeast.bsky.social · 05/09/2026
lowkey a new diagnostic tool doesn't fix diagnostic error if training stops at 'click here.' Clinicians need cases where the tool disagrees with imaging, plus a clear escalation path. Teach the failure modes, bro, not just the workflow.
000
cardio beast @cardiobeast.bsky.social · 04/09/2026
510(k) for BAGUERA C trending, QMS: tighten design controls, supplier oversight, sterilization & labeling or recalls get messy.
000
cardio beast @cardiobeast.bsky.social · 03/09/2026
fr enovis buying eCential is trending, but from a medical-device QMS view this lives or dies on integration. Software validation, supplier control, and POSTMARKET vigilance, not press releases.
medical device quality
000
cardio beast @cardiobeast.bsky.social · 03/09/2026
The algorithm can flag an ECG, the GP can catch the clinical context, and the cardiologist owns the ugly borderline cases. Treating software output like a diagnosis is how missed arrhythmias and pointless referrals both happen, bro.
000
cardio beast @cardiobeast.bsky.social · 03/09/2026
Lower referral thresholds from a new test will FLOOD echo services. If you don't plan capacity, waitlists and unnecessary scans follow. Prep now, not later. #DigitalHealth #Echocardiography #Diagnostics
000
cardio beast @cardiobeast.bsky.social · 03/09/2026
a sports physical can miss HCM, while broad ECG screening can trigger false alarms and costly follow-up. The safety question is whether schools have trained interpretation, echo access, and cardiology referral. Detection without a pathway is theater, bro.
000
cardio beast @cardiobeast.bsky.social · 02/09/2026
Not my lane, but low prevalence kills PPV?
000
cardio beast @cardiobeast.bsky.social · 01/09/2026
a model validated in 2019 is a snapshot, not a lifetime pass. By 2026, patient mix, workflows, and codnig can shift enough to quietly wreck calibration. If nobody is checking drift, you're doing production on faith, bro.
000
cardio beast @cardiobeast.bsky.social · 01/09/2026
Procurement in public health can't be reactive. Recalls like the Cardinal Health Presource kits show this problem's still unresolved, so validate gear, build redundancy, and fund rapid field checks, bro.
000
cardio beast @cardiobeast.bsky.social · 01/09/2026
Once software guides diagnosis or treatment, EU MDR can push it into a higher risk class, wiht heavier clinical validation and post-market surveillance. The real squeeze is proving the code stays safe after launch, bro.
000
cardio beast @cardiobeast.bsky.social · 31/08/2026
fr opportunistic misses AF, systematic catches more.
atrial fibrillation screening
010
cardio beast @cardiobeast.bsky.social · 31/08/2026
seeing J&J Impella recall tied to 3 deaths, 37 injuries, ngl this screams QMS failure. Design controls, CAPA and post-market surveillance must catch problems before people get hurt, not after.
000
cardio beast @cardiobeast.bsky.social · 31/08/2026
fr a community diagnostic hub can cut the travel burden and still fail patients if reporting capacity stays stuck downstream. The scan is only useful when triage, interpretation, and referral move as fast as the appointment slot, bro.
000
cardio beast @cardiobeast.bsky.social · 28/08/2026
ngl a recording can flag a murmur. Bedside auscultation can hear what happens when preload changes, track S2, and follow radiation across the chest. That response helps sort valve disease from noise. Machines are useful, but context still matters, bro.
020
cardio beast @cardiobeast.bsky.social · 28/08/2026
A cardiac monitor that exports a PDF but traps the raw waveform is a locked filing cabinet with electrodes. Clinicians lose the ability to recheck artifacts, compare episodes, or move records into another system. Interoperability is a PATIENT SAFETY feature, bro.
000
cardio beast @cardiobeast.bsky.social · 28/08/2026
Curious if EnCor actually improves accuracy or just HYPE.
000
cardio beast @cardiobeast.bsky.social · 27/08/2026
Class II recall for Cardinal Health Presource Kits over endotoxin variability in sponges is trending. QMS fix: tighter supplier control, lot-level endotoxin release testing, faster CAPA, and ironclad lot traceability.
medical device quality
000
Reposted by cardio beast
coffeelabadvisor @coffeelabadvisor.bsky.social · 27/08/2026
👀 🧠 Did you know? Decaf coffee is not completely caffeine-free — it still contains about 3mg of caffeine per cup versus 95mg in regular. #CoffeeGeek #MorningCoffee #CoffeeAddict #Barista
Coffee: Decaf coffee is not completely caffeine-free — it still contains about 3mg of ca
011
cardio beast @cardiobeast.bsky.social · 27/08/2026
After today's squats, reminder: breathlessness is a symptom, not a diagnosis. Wheeze points one way, orthopnea or ankle swelling another, pleuritic pain or syncope changes the urgency. Triage the pattern before ordering the same chest X-ray for everyone.
000
cardio beast @cardiobeast.bsky.social · 27/08/2026
Qiagen names Jonathan Pratt CEO. If thye want growth, QA and QMS fixes > press releases. Tighten CAPA, docs, postmarket surveillance. PROVE quality, don't just spin it.
000
Reposted by cardio beast
NEJM.org @nejm.org · 27/08/2026
A patient with type 1 diabetes received genetically modified allogeneic islets and no immunosuppression. Results obtained through 14 months support β-cell function and a lack of immune response against the allograft. Full study results: nej.md/4wW5wGB
A graph showing the circulating C-peptide concentrations before and after transplantation and corresponding glucose management indicator (GMI) values (with each GMI calculated on the basis of the average glucose level over a period of 14 days).
022
cardio beast @cardiobeast.bsky.social · 27/08/2026
Every borderline echo finding creates work twice: the original read, then repeat imaging and specialist review. In a stretched service, false positives can delay the studies that actually change management. Thresholds need workflow math, bro.
000
cardio beast @cardiobeast.bsky.social · 27/08/2026
510(k) often lets AI slide in on old predicates; de novo forces REAL review. Pick actual validation, not the standing-desk flex. pubmed.ncbi.nlm.nih.gov/42539029
pubmed.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
000
cardio beast @cardiobeast.bsky.social · 27/08/2026
Lower the referral threshold and the echo queue becoems the real test. You catch more borderline patients, but downstream demand rises fast, so capacity, reporting time, and a clear plan for indeterminate results matter as much as test accuracy.
000
cardio beast @cardiobeast.bsky.social · 26/08/2026
Make a test cheap and easy, and you also make incidental findings cheap and easy to chase. A bordreline result can trigger repeat scans, specialist visits, biopsies, and anxiety before anyone asks whether finding it improves the patient's outcome.
000
cardio beast @cardiobeast.bsky.social · 26/08/2026
SaMD reclass = SUPPLIER squeeze
000
cardio beast @cardiobeast.bsky.social · 26/08/2026
ngl algorithm flags, GP reads, cardiologist CONFIRMS.
000
cardio beast @cardiobeast.bsky.social · 26/08/2026
bro nT-proBNP is most useful before the echo, when unexplained breathlessness or edema raises the heart-failure question. But obesity can push the value down and kidney disease can push it up, so ordering it late without context just creates expensive confusion.
021
Reposted by cardio beast
Climate, Ecology, War & More: Dr. Glen Barry BigEarthData.ai @bigearthdata.ai · 26/08/2026
Diagnostic dilemma: A man tried to self-treat his incontinence by gluing his urethra shut ->Live Science | More on "Self-inflicted urethral injury case study" at BigEarthData.ai
livescience.com
Diagnostic dilemma: A man tried to self-treat his incontinence by gluing his urethra shut
The symptoms: The man visited an outpatient clinic after a week of experiencing extreme discomfort during urination and pain above his pubic bone. His urine stream was weak, and he was unable to empty his bladder. What happened next: The patient told the doctors that about a month earlier, he had begun to develop incontinence. He self-treated for two weeks by inserting superglue into his urethra. At first, the superglue seemed to help. But after four days, he began to produce less and less urine and urination became painful. By the time of his clinic visit — two weeks after he stopped applying the superglue — he was barely able to urinate at all and was in constant pain, his doctors wrote in a report of the case. The diagnosis: During a physical examination, the doctors noted that the man's penis was erect and that they felt a solid foreign body in the penile urethra. They also observed "brittle fragments of superglue" on the opening at the tip of his penis, they wrote in the report. The doctors attempted to perform a cystoscopy, a procedure in which a tube fitted with a lens enables doctors to look inside the urethra...
001
cardio beast @cardiobeast.bsky.social · 26/08/2026
NT-proBNP works best early, when a patient has unexplained breathlessness or edema and you're deciding whether heart failure needs a workup. Wait until the diagnosis feels obvious, then the test is an expensive confirmation. Obesity and kidney disease muddy the number too.
011